News and Announcements
Soar host new bounty programs ahead of public sale dates
- Published October 30, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- Soar’s 33% bonus pre-sale has now closed.
- The Soar public sale dates have now changed from the 9th to the 23rd of November.
- Soar will be celebrating the Soar Testnet by hosting a bounty program.
Soar public sale dates have now changed from the 9th to the 23rd of November, and will now run from the 19th of November to the 3rd of December 2018.
The pre-sale is now closed.
The company will also be celebrating the Soat Testnet, by hosting a bounty program. The program encourages clients to explore the world using their technology, hunt down bounties and share drone photos.
The Soar team will be hosting a live AMA + SKYM Airdrop on November 1st plus a giveaway and an airdrop of 1,000 SKYM tokens.
About Soar
The Soar platform is designed to offer the international community a decentralised marketplace for high quality drone, aerial and satellite imagery, that connects customers with content creators in a secure, trustless and distributed community leveraging blockchain technology. Soar will very soon be the platform for all future mapping, imagery and geospatial information.
Hobbyist drone operators through to professional organisations will be able to monetise unused content in a marketplace driven by the free market forces of supply and demand.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
